MS
Maged Shenouda bought $844K of RLMD stock
Maged Shenouda, Chief Financial Officer of Relmada Therapeutics, Inc. (RLMD), bought 200,000 shares of RLMD stock worth $844K, per an SEC Form 4 filed Sep 11, 2026.
It was an open-market purchase.
The trade happened on Sep 9, 2026, 2 days before it was made public.
RLMD has moved -30.2% since the trade date, from $4.09 to $2.85 (Nov 18, 2026 close).
- Traded
- Sep 9, 2026
- Disclosed
- Sep 11, 2026
- Filing delay
- 2 days
- Price since
- -30.2%
- Role
- Chief Financial Officer
- Source
- SEC Form 4